Lower levels of IFN -γ and IFN-γ-induced genes like CXCL9 contribute to decreased infiltration of CD8+ T cells and are correlated with tumor progression following anti-PD-L1 therapy [82]. This evidence concerns the gene IFNG and neoplasm.